Siemens Healthineers AG Registered Shares

SHL: XETR (DEU)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
?<MLOCK|@@TLOCK|BKF!W^w

Siemens Healthineers Earnings: Chinese Healthcare Remains Muted; Confident 2025 Outlook

Wide-moat Siemens Healthineers reported solid fourth-quarter fiscal 2024 results with revenue reaching EUR 6.3 billion, comparable growth of 5.6%. Investors responded positively with shares rising over 8% at the market’s opening on Nov. 6. While China declined by midsingle digits, other geographies delivered strong growth. Healthineers’ fiscal 2025 outlook is robust 5%-6% revenue growth and margin expansion across all segments, which is in line with our model. We maintain our fair value estimate of EUR 61 per share and view shares as undervalued.

Sponsor Center